226 related articles for article (PubMed ID: 34099896)
1. An emerging role for BAG3 in gynaecological malignancies.
De Marco M; Falco A; Iaccarino R; Raffone A; Mollo A; Guida M; Rosati A; Chetta M; Genovese G; De Caro F; Capunzo M; Turco MC; Uversky VN; Marzullo L
Br J Cancer; 2021 Sep; 125(6):789-797. PubMed ID: 34099896
[TBL] [Abstract][Full Text] [Related]
2. BAG3 expression correlates with the grade of dysplasia in squamous intraepithelial lesions of the uterine cervix.
Raffone A; Travaglino A; D'Antonio A; De Marco M; Caccese M; Mascolo M; Insabato L; Zeppa P; Rosati A; Mollo A; Zullo F; Guida M
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):99-104. PubMed ID: 31444794
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes and genetic networks associated with BAG3‑dependent cell proliferation and cell survival in human cervical cancer HeLa cells.
Furusawa Y; Yunoki T; Hirano T; Minagawa S; Izumi H; Mori H; Hayashi A; Tabuchi Y
Mol Med Rep; 2018 Oct; 18(4):4138-4146. PubMed ID: 30106105
[TBL] [Abstract][Full Text] [Related]
4. Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein.
Ruggiero D; Terracciano S; Lauro G; Pecoraro M; Franceschelli S; Bifulco G; Bruno I
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163936
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers.
Wang ZM; Zhang L; Ren DH; Zhang CY; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(2):2228899. PubMed ID: 37377218
[TBL] [Abstract][Full Text] [Related]
7. BAG3 Protein Is Over-Expressed in Endometrioid Endometrial Adenocarcinomas.
Esposito V; Baldi C; Zeppa P; Festa M; Guerriero L; d'Avenia M; Chetta M; Zullo F; De Laurenzi V; Turco MC; Rosati A; Guida M
J Cell Physiol; 2017 Feb; 232(2):309-311. PubMed ID: 27414463
[TBL] [Abstract][Full Text] [Related]
8. BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells.
Suzuki M; Iwasaki M; Sugio A; Hishiya A; Tanaka R; Endo T; Takayama S; Saito T
Cancer Lett; 2011 Apr; 303(1):65-71. PubMed ID: 21316839
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA regulation of BAG3.
Singh MV; Dhanabalan K; Verry J; Dokun AO
Exp Biol Med (Maywood); 2022 Apr; 247(8):617-623. PubMed ID: 35037515
[TBL] [Abstract][Full Text] [Related]
10. BAG3: a multifaceted protein that regulates major cell pathways.
Rosati A; Graziano V; De Laurenzi V; Pascale M; Turco MC
Cell Death Dis; 2011 Apr; 2(4):e141. PubMed ID: 21472004
[TBL] [Abstract][Full Text] [Related]
11. BAG3: a new therapeutic target of human cancers?
Zhu H; Liu P; Li J
Histol Histopathol; 2012 Mar; 27(3):257-61. PubMed ID: 22237703
[TBL] [Abstract][Full Text] [Related]
12. BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer.
Habata S; Iwasaki M; Sugio A; Suzuki M; Tamate M; Satohisa S; Tanaka R; Saito T
Int J Oncol; 2016 Jul; 49(1):402-10. PubMed ID: 27120977
[TBL] [Abstract][Full Text] [Related]
13. miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.
Wang Y; Tian Y
Oncol Res; 2018 Jul; 26(6):923-931. PubMed ID: 29295729
[TBL] [Abstract][Full Text] [Related]
14. Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity.
Chen Y; Yang LN; Cheng L; Tu S; Guo SJ; Le HY; Xiong Q; Mo R; Li CY; Jeong JS; Jiang L; Blackshaw S; Bi LJ; Zhu H; Tao SC; Ge F
Mol Cell Proteomics; 2013 Oct; 12(10):2804-19. PubMed ID: 23824909
[TBL] [Abstract][Full Text] [Related]
15. Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy.
Qiu S; Sun L; Jin Y; An Q; Weng C; Zheng J
Oncol Rep; 2017 Jul; 38(1):309-316. PubMed ID: 28628188
[TBL] [Abstract][Full Text] [Related]
16. BAG3 contributes to HGF-mediated cell proliferation, migration, and invasion via the Egr1 pathway in gastric cancer.
Lee JC; Koh SA; Lee KH; Kim JR
Tumori; 2019 Feb; 105(1):63-75. PubMed ID: 30514177
[TBL] [Abstract][Full Text] [Related]
17. WW domain of BAG3 is required for the induction of autophagy in glioma cells.
Merabova N; Sariyer IK; Saribas AS; Knezevic T; Gordon J; Turco MC; Rosati A; Weaver M; Landry J; Khalili K
J Cell Physiol; 2015 Apr; 230(4):831-41. PubMed ID: 25204229
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the mystery: How bad is BAG3 in hematological malignancies?
Liu Q; Liu J; Huang X
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188781. PubMed ID: 35985611
[TBL] [Abstract][Full Text] [Related]
19. BAG3 epigenetically regulates GALNT10 expression via WDR5 and facilitates the stem cell-like properties of platin-resistant ovarian cancer cells.
Zhao FY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Liu BQ; Yan J; Li C; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119077. PubMed ID: 34111434
[TBL] [Abstract][Full Text] [Related]
20. At the Crossroads of Apoptosis and Autophagy: Multiple Roles of the Co-Chaperone BAG3 in Stress and Therapy Resistance of Cancer.
Kögel D; Linder B; Brunschweiger A; Chines S; Behl C
Cells; 2020 Feb; 9(3):. PubMed ID: 32121220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
